ArunA Bio adds Tony Townley to its Board of Directors

– USA, GA –  ArunA Bio, Inc., a leader in the development of neural exosomes for the treatment of neurodegenerative diseases, today announced the addition of Tony Townley to its Board of Directors. A long-time entrepreneur and financier, Mr. Townley has overseen financial strategy and operations of fast-growing enterprises for over 30 years.

“We are very pleased to have Tony as both an important investor in ArunA Bio and a member of our Board of Directors,” said Bill Griffin, Chairman of ArunA Bio. “Along with significant financial and operational planning expertise, Tony brings a great deal of experience in managing companies that have incurred spans of rapid adoption and expansion. We look forward to Tony’s contributions as the company grows, and as we continue to make progress in the development of our neural exosome platform for the treatment of neurodegenerative diseases.”

About Tony Townley

Over the last 29 years, Mr. Townley has served as Co-founder, Executive Vice President and Chief Strategy Officer of Zaxby’s Franchising, one of the fastest-growing restaurant franchise systems in the United States. Along with his role in the franchise entity, Mr. Townley, as co-founder, independently operates over 140 of Zaxby’s 910 restaurant locations. Prior to co-founding Zaxby’s, Mr. Townley served six years as Chief Executive Officer for Southern Mortgage & Lending Corporation, a leading mortgage lender in the Southeast U.S. Mr. Townley holds a bachelor’s degree in management from Georgia Southern College and is a charter member of APICS, the American Production Inventory and Control Society.

About ArunA Bio

ArunA Bio is harnessing the natural abilities of neural exosomes to cross the blood-brain barrier and enhance the body’s anti-inflammatory, self-repair and protective mechanisms to treat a range of neurodegenerative disorders. ArunA Bio is also leveraging its proprietary exosomes and manufacturing platform to create synergistic therapies by enhancing exosomes with RNA, oligonucleotides, antibodies and small molecules.

For more information:

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.